Skip to main content

HubXchange

HubXChange logo

Immuno-Oncology Xchange - San Francisco - 2024

Page Banner 1

  1. Immune Biomarkers
    • Immune Biomarkers
    Sponsor Led Poster Session
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Afternoon Refreshments
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Evening Drinks Reception
  4. Tumor Microenvironment (TME)
    • Tumor Microenvironment (TME)
    Development of multiplex technologies to develop combination drug strategies (TOPIC & FACILITATOR TBC)
     
    Pamela Reilly Contag
    Pamela Reilly Contag, PhD, Chief Executive Officer - BioEclipse Therapeutics
  5. Clinical Development
    • Clinical Development
    Clinical development translational medicine
     
    Anthony Maida
    Anthony Maida, Chief Clinical Officer - Translational Medicine - Oncotelic Therapeutics
  6. Immune Biomarkers
    • Immune Biomarkers
    Addressing the tissue limitations with liquid biopsy - are we ready to bring non-invasive tools to the market? (FACILITATOR TBC)
  7. Tumor Microenvironment (TME)
    • Tumor Microenvironment (TME)
    Sponsor Led Poster Session
  8. Clinical Development
    • Clinical Development
    Sponsor Led Poster Session
  9. Translational Research
    • Translational Research
    Sponsor Led Poster Session
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Spotlight Presentation
    Spotlight Presentation
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    1-2-1 Meetings / Networking Break
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    1-2-1 Meetings / Networking Break
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Spotlight Presentation: NGS in Immuno-oncology: Current Advancements and Ongoing Challenges
    Spotlight Presentation: NGS in Immuno-oncology: Current Advancements and Ongoing Challenges
    The applications of next-generation sequencing (NGS) are playing an emerging role in immune-oncology ...
    Yiming Guo, PhD
    Yiming Guo, PhD, Scientist, Translational Medicine - Burning Rock Dx
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Networking Lunch
  15. Tumor Microenvironment (TME)
    • Tumor Microenvironment (TME)
    Sponsor Led Roundtable Discussion
  16. Clinical Development
    • Clinical Development
    Sponsor Led Roundtable Discussion
  17. Translational Research
    • Translational Research
    Sponsor Led Roundtable Discussion
  18. Immune Biomarkers
    • Immune Biomarkers
    Sponsor Led Roundtable Discussion
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Morning Refreshments
    Thomson Hall - First Floor
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    1-2-1 Meetings / Networking Break
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    1-2-1 Meetings / Networking Break
  22. Tumor Microenvironment (TME)
    • Tumor Microenvironment (TME)
    Challenges in leveraging preclinical learnings to inform MoA in translational/clinical research
    Melissa Kachura
    Melissa Kachura, Associate Director, Translational Immunology - Gritstone Bio
  23. Clinical Development
    • Clinical Development
    The challenge of overcoming resistance to anti-PD(L1)-1 checkpoint inhibitors
     
    Satya Das
    Satya Das, Senior Medical Director, Clinical Development - Cullgen
  24. Translational Research
    • Translational Research
    Translational strategies to develop clinically safe and effective immune cell engagers
     
    Udaya Rangaswamy
    Udaya Rangaswamy, Director Translational Biology - Rondo Therapeutics
  25. Immune Biomarkers
    • Immune Biomarkers
    Biomarker identification in blood for improved cancer diagnosis and response monitoring to immune-checkpoint blockade
     
    Connie Tat
    Connie Tat, Senior Medical Science Director - Genentech
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Opening Address & Keynote Presentation
    • Immune Biomarkers
    • Translational Research
    • Clinical Development
    • Tumor Microenvironment (TME)
    Registration
Search